Epstein-Barr virus-containing epithelial cells from nasopharyngeal carcinoma produce interleukin 1 alpha.
- 1 September 1987
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 84 (17) , 6262-6266
- https://doi.org/10.1073/pnas.84.17.6262
Abstract
Nasopharyngeal carcinoma (NPC) is a human epithelial cancer that is constantly associated with the Epstein-Barr virus (EBV). Investigations on this tumor have been limited so far by the difficulty of culturing NPC cells for long periods. C15 is an NPC tumor that has been successfully carried in nude mice for greater than 2 yr. C15 cells isolated from the animal were shown to produce a soluble factor with interleukin 1 (IL-1) activity. Its biochemical (Mr, approximately equal to 17,000; pI approximately equal to 5) and immunological properties are identical to those of IL-1 alpha. RNA gel blot analysis showed IL-1 alpha, but not IL-1 beta, transcripts in C15 cells, in sharp contrast to monocytes that express IL-1 beta predominantly. Media from short-term cultures of fresh NPC biopsies also contained a strong IL-1 activity. Several lymphoblastoid cell lines obtained by EBV infection of normal B lymphocytes have been shown to produce IL-1 and use it as an autocrine growth factor. The production of IL-1 by malignant EBV-containing epithelial cells indicates that different types of EBV-infected cells produce IL-1. A relationship might exist between EBV and constitutive production of IL-1. The IL-1 produced by the malignant epithelial cells in vivo could stimulate the development of the pronounced T-cell infiltrate observed in NPC tumors.This publication has 24 references indexed in Scilit:
- Nucleotide sequence of human monocyte interleukin 1 precursor cDNA.Proceedings of the National Academy of Sciences, 1984
- Accessory cell function of human B cells. I. Production of both interleukin 1-like activity and an interleukin 1 inhibitory factor by an EBV-transformed human B cell line.The Journal of Experimental Medicine, 1984
- Epidermal cytokines: properties of epidermal cell thymocyte-activating factor (ETAF).1984
- Interleukin 1, a potential regulator of fibroblast proliferation.The Journal of Immunology, 1982
- Subsets of human Ia-like molecules defined by monoclonal antibodiesMolecular Immunology, 1981
- Purification to apparent homogeneity of murine interleukin 1.The Journal of Immunology, 1981
- T Cell Growth Factor: Parameters of Production and a Quantitative Microassay for ActivityThe Journal of Immunology, 1978
- CHARACTERIZATION OF LYMPHOCYTE-ACTIVATING FACTOR (LAF) PRODUCED BY MACROPHAGE CELL LINE, P388D1 .1. ENHANCEMENT OF LAF PRODUCTION BY ACTIVATED T-LYMPHOCYTES1978
- Human leukocytic pyrogen: purification and development of a radioimmunoassay.Proceedings of the National Academy of Sciences, 1977
- Direct Evidence for the Presence of Epstein-Barr Virus DNA and Nuclear Antigen in Malignant Epithelial Cells from Patients with Poorly Differentiated Carcinoma of the NasopharynxProceedings of the National Academy of Sciences, 1974